Atorvastatin For The Reduction Of Ventricular Arrhythmias

Mise à jour : Il y a 4 ans
Référence : NCT00457340

Femme et Homme

Extrait

To assess in patients with CAD [coronary artery disease] and an implantable defibrillator the effect of atorvastatin 80 mg versus placebo on the first recurrence of a ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation requiring ICD [implantable cardioverter defibrillator] intervention) within one year after randomization.


Critère d'inclusion

  • Arrhythmia

Liens